Ind Swift Laboratories Ltd (ISLB.NS)
ISLB.NS on National Stock Exchange of India
41.35INR
24 May 2013
41.35INR
24 May 2013
Price Change (% chg)
Rs-0.20 (-0.48%)
Rs-0.20 (-0.48%)
Prev Close
Rs41.55
Rs41.55
Open
Rs42.00
Rs42.00
Day's High
Rs43.00
Rs43.00
Day's Low
Rs41.15
Rs41.15
Volume
35,923
35,923
Avg. Vol
70,678
70,678
52-wk High
Rs85.70
Rs85.70
52-wk Low
Rs38.95
Rs38.95
ISLB.NS
About
Ind-Swift Laboratories Limited is engaged in the manufacture of Active Pharmaceutical Ingredients (API). The Company operates in a single business segment, Bulk Drugs and Pharmaceuticals. The Company Derabassi facilities manufacturing block include containment facility for high potency drugs, a menthol facility and Power plant.... (more)
No analyst recommendations are available for ISLB.NS.
Overall
| Beta: | 1.32 |
| Market Cap (Mil.): | Rs1,623.83 |
| Shares Outstanding (Mil.): | 39.27 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ISLB.NS | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 2.53 | 34.14 | 34.28 |
| EPS (TTM): | 16.37 | -- | -- |
| ROI: | -- | 19.49 | 18.85 |
| ROE: | -- | 20.26 | 19.72 |
Earnings vs. 
Estimates
No consensus analysis data available.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
